Results 11 to 20 of about 1,899,013 (161)

Functional Tricuspid Regurgitation in the Transcatheter Aortic Valve Replacement Population and Emerging Transcatheter Tricuspid Valve Interventions [PDF]

US Cardiology Review
Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic valve disease. However, its success has brought attention to concurrent tricuspid valve disease and the inadequacy of treatments.
Molly Silkowski, Payton Kendsersky, Nicholas Amoroso   +2 more
doaj   +4 more sources

Imaging and Patient Selection for Transcatheter Tricuspid Valve Interventions [PDF]

Frontiers in Cardiovascular Medicine, 2020
With the emergence of transcatheter solutions for the treatment of tricuspid regurgitation (TR) increased attention has been directed to the once neglected tricuspid valve (TV) complex.
Mirjam G. Winkel, Nicolas Brugger, Omar K. Khalique, Christoph Gräni, Adrian Huber, Thomas Pilgrim, Michael Billinger, Stephan Windecker, Rebecca T. Hahn, Fabien Praz   +9 more
doaj   +8 more sources

Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review

Reviews in Cardiovascular Medicine
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk.
Sara Veneziano, Sabrina Trippoli, Andrea Messori, Vincenzo Calderone, Eugenia Piragine   +4 more
doaj   +5 more sources

Mitral and Tricuspid Transcatheter Interventions Current Indications and Future Directions [PDF]

Frontiers in Cardiovascular Medicine, 2020
Valvular heart disease is responsible for a high rate of morbidity and mortality, especially in the elderly population. With the emergence of new transcatheter treatment options, the therapeutic spectrum for patients with valvular heart disease has ...
Mirjam Gauri Winkel, Fabien Praz, Peter Wenaweser, Peter Wenaweser   +3 more
doaj   +4 more sources

Echocardiographic guidance in transcatheter tricuspid valve interventions

Journal of Cardiovascular Imaging
Abstract Echocardiographic guidance plays a pivotal role in pre-procedural screening and intraprocedural guidance for transcatheter tricuspid valve interventions (TTVI). Pre-procedurally, comprehensive transesophageal echocardiography (TEE) is essential to understand the tricuspid regurgitation (TR) mechanism, quantify TR severity ...
Kevin Ka Ho Kam, Mani Vannan, Alex Pui Wai Lee   +2 more
openaire   +4 more sources

Transcatheter Tricuspid Valve Interventions: An Emerging Field

Current Cardiology Reports, 2019
This review aims to provide an updated overview and a clinical perspective on novel transcatheter tricuspid valve interventions (TTVI), highlighting potential challenges and future directions.Severe tricuspid regurgitation (TR) is a predictor of mortality.
Gheorghe, Livia, Rensing, Benno J.W.M., Van der Heyden, Jan A.S., Eefting, Frank D., Post, Martijn C., Rana, Bushra, Swaans, Martin J.   +6 more
openaire   +4 more sources

Transcatheter tricuspid valve interventions: Current status and future perspectives

Frontiers in Cardiovascular Medicine, 2022
The development of transcatheter therapies to treat valvular heart diseases has changed the rules of the game, particularly in the case of aortic stenosis and mitral regurgitation.
Alberto Alperi, Alberto Alperi, Marcel Almendárez, Marcel Almendárez, Rut Álvarez, Rut Álvarez, Cesar Moris, Cesar Moris, Cesar Moris, Victor Leon, Victor Leon, Iria Silva, Iria Silva, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Isaac Pascual, Isaac Pascual, Isaac Pascual, Pablo Avanzas, Pablo Avanzas, Pablo Avanzas   +21 more
doaj   +4 more sources

Exploration of Anesthetic Strategies for Transcatheter Tricuspid Valve Intervention

Reviews in Cardiovascular Medicine
Tricuspid regurgitation (TR) is a critical factor in the progression of right heart failure. Although conventional open surgery remains the definitive treatment, the application of this technique is significantly limited in older and high-risk patients ...
Shuantong Lin, Yulong Guan
doaj   +4 more sources

Transcatheter treatment for tricuspid valve disease. [PDF]

, 2021
Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve apparatus and is observed in only 8-10% of the patients with tricuspid valve ...
Maisano, Francesco, Praz, F., Kreidel, F., Mangieri, A., Prendergast, B.D., Muraru, Denisa, Hahn, Rebecca T, Zamorano, Jose L, Mangieri, Antonio, Zamorano, J.L., von Bardeleben, Ralph Stephan, Hausleiter, Jörg, Maisano, F., Nickenig, G., Prendergast, Bernard D, Bardeleben, R.S. von, Senni, Michele, Nickenig, Georg, Delgado, V., Praz, Fabien, Lurz, P., Senni, M., Delgado, Victoria, Hausleiter, J., Lurz, Philipp, Hahn, R.T., Kreidel, Felix, Muraru, D., Felix Kreidel, Philipp Lurz, Michele Senni, Jörg Hausleiter, Fabien Praz, Rebecca T. Hahn, Ralph Stephan von Bardeleben, Denisa Muraru, Jose L. Zamorano, Antonio Mangieri, Bernard D. Prendergast, Victoria Delgado, Francesco Maisano, Georg Nickenig   +41 more
core   +2 more sources

Transcatheter Tricuspid Valve Intervention: Current Perspective

US Cardiology Review, 2021
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which generates interest in therapeutic approaches to mitigate these effects. Historically, therapeutic options for TR were limited to surgical approaches, which are often complicated by significant morbidity and mortality in elderly patients with multiple ...
Trevor J Simard, Mackram F Eleid
openaire   +3 more sources